| Date Filed | Type | Description |
| 08/09/2023 |
4
| Mayo Stephen (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $4.2855, valued at
$42.9k
|
|
| 08/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/31/2023 |
4
| Mayo Stephen (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 1,981 options to buy
@ $111.07, valued at
$220k
|
|
| 03/08/2023 |
4
| Mayo Stephen (Director) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Granted 1,523 shares
@ $0
Granted 3,257 options to buy
@ $155.99, valued at
$508.1k
|
|
| 11/21/2022 |
4
| Mayo Stephen (Director) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Sold 858 shares
@ $109.92, valued at
$94.3k
|
|
| 07/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2021 |
4
| Mayo Stephen (Director) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Granted 4,292 shares
@ $0
Granted 8,238 options to buy
@ $83, valued at
$683.8k
|
|
| 11/17/2021 |
3
| Mayo Stephen (Director) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |